Cargando…
Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer
Acute generalized exanthematous pustulosis (AGEP) is a rare drug-related adverse skin reaction caused mainly by antibiotics. Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) used to treat lung cancer. A 69-year-old woman with primary lung cancer (adenocarcinoma,...
Autores principales: | Komiya, Natsuko, Takahashi, Koichiro, Kato, Go, Kubota, Mio, Tashiro, Hiroki, Nakashima, Chiho, Nakamura, Tomomi, Iwanaga, Kentaro, Kimura, Shinya, Sueoka-Aragane, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077539/ https://www.ncbi.nlm.nih.gov/pubmed/33976640 http://dx.doi.org/10.1159/000514146 |
Ejemplares similares
-
A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Mycobacterium avium Complex Pulmonary Disease
por: Sadamatsu, Hironori, et al.
Publicado: (2021) -
Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report
por: Tashiro, Hiroki, et al.
Publicado: (2016) -
Factors related to the diagnosis of lung cancer by transbronchial biopsy with endobronchial ultrasonography and a guide sheath
por: Kurihara, Yuki, et al.
Publicado: (2022) -
Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan
por: Kurihara, Yuki, et al.
Publicado: (2020) -
Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer
por: Komiya, Kazutoshi, et al.
Publicado: (2019)